[{"NetIncomeLoss_1_Q2_USD":4068000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":33000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":2000.0,"AccumulatedAmortizationDeferredFinanceCosts_0_Q2_USD":120000.0,"Depreciation_2_Q2_USD":1288000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-40937000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-107000.0,"AssetsCurrent_0_Q2_USD":228172000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":84751000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":357000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":11974000.0,"RestrictedCashCurrent_0_Q2_USD":0.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-22000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2_Q2_USD":0.0,"OperatingLeaseLiability_0_Q2_USD":949000.0,"InterestPaidNet_2_Q2_USD":76000.0,"DefinedContributionPlanCostRecognized_1_Q2_USD":921000.0,"OperatingLeaseExpense_2_Q2_USD":371000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":79795000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_Q2_shares":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":51000.0,"Assets_0_Q2_USD":253559000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":135943000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":2408000.0,"CommonStockSharesIssued_0_Q2_shares":49828829.0,"IncomeTaxesPaidNet_2_Q2_USD":158000.0,"OperatingLeaseExpense_1_Q2_USD":186000.0,"OperatingLeaseLeaseIncomeLeasePayments_1_Q2_USD":199000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":6000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":12000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":34000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":193000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4814000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":9437000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":42897000.0,"OperatingLeaseLeaseIncomeLeasePayments_2_Q2_USD":398000.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":1759000.0,"Liabilities_0_Q2_USD":31738000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":237764000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":210000.0,"AccountsReceivableNetCurrent_0_Q2_USD":31497000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-32000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-78000.0,"ProceedsFromStockPlans_2_Q2_USD":1882000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":55595016.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":55665193.0,"IncomeTaxExpenseBenefit_1_Q2_USD":12000.0,"PaymentsOfFinancingCosts_2_Q2_USD":0.0,"EarningsPerShareBasic_1_Q2_USD":0.08,"EarningsPerShareBasic_2_Q2_USD":0.23,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":975000.0,"DeferredFinanceCostsGross_0_Q2_USD":430000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":11630000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":19793000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-126000.0,"DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_2_Q2_USD":1.0,"CommonStockValue_0_Q2_USD":50000.0,"CapitalizedContractCostNet_0_Q2_USD":479000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":156000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":91322000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":7276000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":4119000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":11426000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q2_USD":-706000.0,"IncreaseDecreaseInInventories_2_Q2_USD":7523000.0,"ProceedsFromNotesPayable_2_Q2_USD":0.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":0.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":0.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":256588.0,"TenantImprovements_0_Q2_USD":13100000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1700000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.003,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.018,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":0.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q2_shares":0.0,"ShareBasedCompensation_2_Q2_USD":8440000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":868000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3730000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":16068000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":57000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-123000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4604000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":755000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":4080000.0,"ProceedsFromWarrantExercises_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":11747000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":51000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-111000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3320000.0,"AmortizationOfFinancingCosts_2_Q2_USD":76000.0,"RestrictedCashNoncurrent_0_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EarningsPerShareDiluted_1_Q2_USD":0.07,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":19000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":49512800.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":49669652.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":486000.0,"NetIncomeLoss_2_Q2_USD":11537000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":10827000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_2_Q2_pure":0.04,"PreferredStockSharesIssued_0_Q2_shares":0.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_Q2_shares":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.029,"GrossProfit_1_Q2_USD":58639000.0,"GrossProfit_2_Q2_USD":111413000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":573000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2497000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":91322000.0,"InterestExpense_1_Q2_USD":74000.0,"InterestExpense_2_Q2_USD":147000.0,"AccountsPayableCurrent_0_Q2_USD":10319000.0,"LiabilitiesCurrent_0_Q2_USD":31582000.0,"EarningsPerShareDiluted_2_Q2_USD":0.21,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":406000.0,"CommonStockSharesOutstanding_0_Q2_shares":49828829.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-23295000.0,"InvestmentIncomeInterest_1_Q2_USD":35000.0,"InvestmentIncomeInterest_2_Q2_USD":103000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":0.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":0.0,"InventoryNet_0_Q2_USD":18112000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":40000.0,"OperatingIncomeLoss_1_Q2_USD":4112000.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":11825000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":120850000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DeferredFinanceCostsNet_0_Q2_USD":310000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":16000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":26000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":63453000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":253559000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":16041000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-15886000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":50000000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":135926000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6186000.0,"StockholdersEquity_0_Q2_USD":221821000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":0.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":0.0,"ProfitLoss_2_Q2_USD":11537000.0,"DefinedBenefitPlanContributionsByEmployer_2_Q2_USD":1.0,"OperatingExpenses_1_Q2_USD":54527000.0,"OperatingExpenses_2_Q2_USD":99588000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":793000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":14147000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":41833000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4604000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8440000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":3470000.0,"ShortTermInvestments_0_Q2_USD":84744000.0,"Ticker":"NARI","CIK":"1531048","name":"INARI MEDICAL, INC.","OfficialName":"Inari Medical Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4973580587.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]